Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells

Haematologica. 2008 Mar;93(3):413-22. doi: 10.3324/haematol.11646. Epub 2008 Feb 20.

Abstract

Background: Patients with chronic lymphocytic leukemia whose cells express CD38 and ZAP-70 and utilize unmutated Ig VH region genes have a very poor prognosis. We studied whether cells expressing CD38 and ZAP-70 are more susceptible to stimulation through B-cell receptors than are cells that do not express CD38 and ZAP-70.

Design and methods: CD38-positive and CD38-negative leukemic cells were separated from single cases and compared for their response to B-cell receptor cross-linking and ZAP-70 expression. Cohort studies were also carried out by measuring the apoptotic response to surface immunoglobulin M (IgM) cross-linking in 82 patients with chronic lymphocytic leukemia and the protein tyrosine phosphorylation induced by surface IgM in 21 patients.

Results: CD38-positive cells, isolated from cases of chronic lymphocytic leukemia classified as CD38-positive or CD38-negative, expressed more ZAP-70 than the corresponding CD38-negative cells, exhibited more robust protein tyrosine phosphorylation and had a greater tendency to apoptosis upon B-cell receptor cross-linking. In the cohort studies, surface IgM-induced protein tyrosine phosphorylation correlated significantly with CD38 and ZAP-70 expression and with the absence of Ig VH gene mutations. Apoptosis induced by surface IgM cross-linking correlated significantly only with the proportion of CD38-positive cells. Difficulties in finding more definitive correlations were probably related to imprecision in the in vitro test system and in the definition of cases as positive or negative.

Conclusions: Collectively, these data indicate that CD38-positive, ZAP-70-positive cells have a greater capacity for signaling through the B-cell receptor and suggest a function for B-cell receptor signaling in promoting chronic lymphocytic leukemia cell expansion, especially within the CD38-positive fraction of the leukemic clone.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-ribosyl Cyclase 1 / analysis*
  • Apoptosis / immunology
  • Biomarkers
  • Clone Cells / chemistry
  • Clone Cells / immunology
  • Cohort Studies
  • Humans
  • Immunoglobulin M / immunology*
  • Immunologic Capping
  • Leukemia, Lymphocytic, Chronic, B-Cell / pathology*
  • Neoplastic Stem Cells / chemistry
  • Neoplastic Stem Cells / immunology*
  • Phosphorylation
  • Protein Processing, Post-Translational
  • Protein-Tyrosine Kinases / metabolism
  • Receptors, Antigen, B-Cell / immunology*
  • Signal Transduction / immunology
  • Tumor Cells, Cultured / cytology
  • Tumor Cells, Cultured / immunology
  • ZAP-70 Protein-Tyrosine Kinase / analysis*

Substances

  • Biomarkers
  • Immunoglobulin M
  • Receptors, Antigen, B-Cell
  • Protein-Tyrosine Kinases
  • ZAP-70 Protein-Tyrosine Kinase
  • ZAP70 protein, human
  • ADP-ribosyl Cyclase 1